Evoq Remedies Ltd
Incorporated in 2010, EVOQ Remedies
Ltd is engaged in the trading of pharmaceuticals formulation and allied products[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
1d - Submission of SEBI regulation 74(5) certificate for Q1 FY2025-26 on securities dematerialisation.
-
Board Meeting Outcome for Outcome Of Board Meeting And Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
7 Jun - Appointed Ms. Nikita Jain as Company Secretary and Compliance Officer effective 7 June 2025.
-
Appointment of Company Secretary and Compliance Officer
7 Jun - Appointed Ms. Nikita Jain as Company Secretary and Compliance Officer effective 7 June 2025.
-
Submission Of Voting Results For The Extra-Ordinary General Meeting Held On 3Rd June, 2025 At 03:02 PM Through VC/OAVM.
5 Jun - Evoq Remedies passed 5 resolutions including share capital increase and preferential allotment on June 3, 2025.
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
5 Jun - Scrutinizer's report confirms unanimous approval of all resolutions at Evoq Remedies' EGM on 3 June 2025.
Business Overview:[1][2]
Company is in the business of marketing, trading, and distribution of a wide range of pharmaceutical formulation products. Apart from this, the company also deals in trading of active pharmaceutical ingredients, Nutraceutical, Ayurvedic, and Herbal Products